Agastiya Biotech
PrivateLast Round
Series A
Mar 15, 2026
Company Overview
Agastiya Biotech operates in Healthcare & Life Sciences and is based in Temecula, California. It was founded in 2019.
Agastiya Biotech is a biotechnology company that develops novel small molecule oncology therapeutics for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agastiya Biotech Comparables
Compare Agastiya Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspera Biomedicines | 81% | |
| Avenzoar Pharmaceuticals | 78% | |
| StemSynergy Therapeutics, Inc. | 78% |
For institutional investors. Book with your work email.
Agastiya Biotech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
Monthly visitors grew 463% MoM, from 71 to 400.
For institutional investors. Book with your work email.
Agastiya Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Agastiya Biotech's valuation, stock price, and market status.
Is Agastiya Biotech a public or private company?
Agastiya Biotech is a private company.
What is the current stock price of Agastiya Biotech?
Agastiya Biotech is a private company, so its shares have no public market price. Caplight tracks Agastiya Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Agastiya Biotech worth (valuation)?
Valuation information for Agastiya Biotech is not publicly available.
Can I buy Agastiya Biotech stock?
Agastiya Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Agastiya Biotech's last funding round?
Agastiya Biotech's most recent funding round was Series A on March 15, 2026.
Who are the main investors in Agastiya Biotech?
Investor information for Agastiya Biotech is not publicly disclosed.
Will Agastiya Biotech IPO soon?
No public IPO plans have been announced for Agastiya Biotech.
How can I track Agastiya Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Agastiya Biotech's shares on secondary markets.